Cargando…
Nebivolol therapy improves QTc and QTcd parameters in heart failure patients
AIM: It has previously been shown that β-blocker therapy reduces QT dynamics in heart failure patients. The aim of this study was to demonstrate this improvement with the third-generation β-blocker, nebivolol. METHODS: A total of 72 heart failure patients with systolic dysfunction were included in t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721958/ https://www.ncbi.nlm.nih.gov/pubmed/22614660 http://dx.doi.org/10.5830/CVJA-2011-046 |